Q2
PFE — Q2 2026 Financial Report Analysis
Pfizer posted a $248 million net loss in Q2 2026 as a $4.3 billion writedown of acquired research assets overwhelmed 2.6% revenue growth, while COVID product revenue fell to $282 million and the rest of the portfolio grew about 5% operationally.